📣 VC round data is live. Check it out!

Abbott India Valuation Multiples

Discover revenue and EBITDA valuation multiples for Abbott India and similar public comparables like PTC Therapeutics, Scholar Rock, Celcuity, Terns Pharma and more.

Abbott India Overview

About Abbott India

Abbott India Ltd is a drug manufacturing company that offers products in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. Its patient focus centers overwhelmingly on women's health and gastrointestine, gastroenterology, and hepatic care. Geographically, the majority of the company's revenue is generated in India.


Founded

1944

HQ

India

Employees

3.7K

Financials (LTM)

Revenue: $732M
EBITDA: $201M

EV

$6B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Abbott India Financials

Abbott India reported last 12-month revenue of $732M and EBITDA of $201M.

In the same LTM period, Abbott India generated $342M in gross profit, $201M in EBITDA, and $165M in net income.

Revenue (LTM)


Abbott India P&L

In the most recent fiscal year, Abbott India reported revenue of $670M and EBITDA of $206M.

Abbott India is profitable as of last fiscal year, with gross margin of 45%, EBITDA margin of 31%, and net margin of 22%.

See analyst estimates for Abbott India
LTMLast FY202320242025202620272028
Revenue$732M$670M$598M$655M$711M
Gross Profit$342M$303M$267M$295M$329M
Gross Margin47%45%45%45%46%
EBITDA$201M$206M$169M$199M$200M
EBITDA Margin27%31%28%30%28%
EBIT Margin28%26%23%25%28%
Net Profit$165M$148M$119M$142M$160M
Net Margin23%22%20%22%22%

Financial data powered by Morningstar, Inc.

Abbott India Stock Performance

Abbott India has current market cap of $6B, and enterprise value of $6B.

Market Cap Evolution


Abbott India's stock price is $285.06.

Abbott India share price increased by 6.4% in the last 30 days, and decreased by 13.5% in the last year.

Abbott India has an EPS (earnings per share) of $6.96.

See more trading valuation data for Abbott India
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$6B$6B1.1%6.4%0.5%-13.5%$6.96

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Abbott India Valuation Multiples

Abbott India trades at 8.0x EV/Revenue multiple, and 29.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Abbott India

EV / Revenue (LTM)


Abbott India Financial Valuation Multiples

As of May 14, 2026, Abbott India has market cap of $6B and EV of $6B.

Abbott India has a P/E ratio of 36.6x.

LTMLast FY202320242025202620272028
EV/Revenue8.0x8.7x9.7x8.9x8.2x
EV/EBITDA29.1x28.3x34.5x29.3x29.1x
EV/EBIT28.1x33.9x41.6x35.2x29.6x
EV/Gross Profit17.0x19.3x21.9x19.7x17.7x
P/E36.6x41.0x50.9x42.6x38.0x
EV/FCF37.7x58.1x51.2x55.2x42.4x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Abbott India Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Abbott India Margins & Growth Rates

Abbott India grew revenue by 8% but EBITDA decreased by 4% in the last fiscal year.

In the most recent fiscal year, Abbott India reported gross margin of 45%, EBITDA margin of 31%, and net margin of 22%.

See estimated margins and future growth rates for Abbott India

Abbott India Margins

Last FY202420252026202720282029
Gross Margin45%45%46%47%
EBITDA Margin31%30%28%28%
EBIT Margin26%25%28%28%
Net Margin22%22%22%23%
FCF Margin15%16%19%23%

Abbott India Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth8%10%8%9%
Gross Profit Growth12%11%12%10%
EBITDA Growth(4%)18%1%7%
EBIT Growth19%18%19%11%
Net Profit Growth11%20%12%10%
FCF Growth49%(7%)30%31%

Data powered by FactSet, Inc. and Morningstar, Inc.

Abbott India Operational KPIs

Abbott India's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.

Abbott India's Rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Abbott India's Rule of X is 49% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Abbott India
LTMLast FY202320242025202620272028
Rule of 4036%36%———
Bessemer Rule of X49%49%———
Revenue per Employee—$0.2M———
Opex per Employee—$0.0M———
S&M Expenses to Revenue—3%4%3%3%
G&A Expenses to Revenue—2%2%2%2%
Opex to Revenue—20%21%20%18%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Abbott India Competitors

Abbott India competitors include PTC Therapeutics, Scholar Rock, Celcuity, Terns Pharma, Centessa Pharmaceuticals, Corcept Therapeutics, Belite Bio, Immunovant, Hebei Changshan and Salubris Pharmaceuticals.

Most Abbott India public comparables operate across Biopharmaceuticals, Medical Devices, BioTech, DeepTech, FemTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
PTC Therapeutics2.7x3.0x5.1x6.9x
Scholar Rock—2434.7x(15.5x)(14.2x)
Celcuity—280.3x(36.9x)(30.4x)
Terns Pharma————
Centessa Pharmaceuticals397.7x628.5x(32.5x)(26.7x)
Corcept Therapeutics7.6x6.9x44.5x46.3x
Belite Bio—685.0x(73.4x)(61.5x)
Immunovant——(12.3x)(10.7x)

This data is available for Pro users. Sign up to see all Abbott India competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Abbott India

When was Abbott India founded?Abbott India was founded in 1944.
Where is Abbott India headquartered?Abbott India is headquartered in India.
How many employees does Abbott India have?As of today, Abbott India has over 3K employees.
Is Abbott India publicly listed?Yes, Abbott India is a public company listed on National Stock Exchange of India.
What is the stock symbol of Abbott India?Abbott India trades under ABBOTINDIA ticker.
When did Abbott India go public?Abbott India went public in 2010.
Who are competitors of Abbott India?Abbott India main competitors include PTC Therapeutics, Scholar Rock, Celcuity, Terns Pharma, Centessa Pharmaceuticals, Corcept Therapeutics, Belite Bio, Immunovant, Hebei Changshan, Salubris Pharmaceuticals.
What is the current market cap of Abbott India?Abbott India's current market cap is $6B.
What is the current revenue of Abbott India?Abbott India's last 12 months revenue is $732M.
What is the current revenue growth of Abbott India?Abbott India revenue growth (NTM/LTM) is 9%.
What is the current EV/Revenue multiple of Abbott India?Current revenue multiple of Abbott India is 8.0x.
Is Abbott India profitable?Yes, Abbott India is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Abbott India?Abbott India's last 12 months EBITDA is $201M.
What is Abbott India's EBITDA margin?Abbott India's last 12 months EBITDA margin is 27%.
What is the current EV/EBITDA multiple of Abbott India?Current EBITDA multiple of Abbott India is 29.1x.
What is the current FCF of Abbott India?Abbott India's last 12 months FCF is $155M.
What is Abbott India's FCF margin?Abbott India's last 12 months FCF margin is 21%.
What is the current EV/FCF multiple of Abbott India?Current FCF multiple of Abbott India is 37.7x.
How many companies Abbott India has acquired to date?Abbott India hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Abbott India has invested to date?Abbott India hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Abbott India

Lists including Abbott India

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial